Quinoa VS Reliv

Diabetes

According to the American Diabetes Association, nearly 30 million people in the US have diabetes. Another 86 million have pre-diabetes and are at risk for developing diabetes. Diabetes can shave a decade or more off the lives of those who choose to ignore its damaging tendencies.
Day to day, it can cause high blood pressure, infections and inflammation – the root of aches, pains and organ deterioration.

Cardiovascular problems, including coronary artery disease with chest pain, heart attack, stroke and narrowing of arteries. If you have diabetes, you are more likely to have heart disease or stroke. 
At least half of all people with diabetes may have signs of early kidney problems. The kidneys contain millions of tiny blood vessel clusters that filter waste from your blood. Diabetes can damage this delicate filtering system and severe damage can lead to kidney failure or irreversible end-stage kidney disease. 

Damage to the blood vessels at the back of the eyes can occur without you being aware of it. Vision may seem unchanged until the problem is severe. There are certain symptoms that may occur. Flashes of light, floaters, blots and dots or vision partly missing. 

A Note from Dr. Carl: Supporting healthy blood sugar levels, one can at a time

Diabetes is a serious health concern in our country and around the world. Those suffering from diabetes and metabolic syndrome need all the support they can get. Here at Reliv, we've developed a product specifically for supporting healthy blood sugar levels: patented GlucAffect® with LunaRich®.

In an 8-week placebo-controlled clinical study, four servings of GlucAffect lowered the fasting glucose levels of overweight individuals by 30%. Plus, these individuals were able to lose an average of 16 lbs. in those 8 weeks. Losing weight can be a tremendous help in the fight against diabetes and metabolic syndrome.

With GlucAffect and the combination of Reliv Now and LunaRich X, Reliv is leading the way in delivering cutting-edge nutritional solutions for the metabolic health challenges we face today.

To your health,
Dr. Carl W. Hastings
Vice Chairman and Chief Scientific Officer

No purchase required to become a member. RCN# 173198904 Reliv.com 

DHA

Symptoms of omega-3 fatty acid deficiency include fatigue, poor memory, dry skin, heart problems, mood swings or depression, and poor circulation. Deficiencies in omega-3 are being blamed for many of today’s mental issues, from attention-deficit hyperactivity disorders (ADHD) to mood disorders such as depression. With the fast-paced, high-stress lives we lead, brain drain is a common side effect. Can’t remember where we put the car keys. Grasping at words or names. Slow, dull thinking. Lack of spark, initiative or creativity at work. Stress-induced fatigue. People of every age can benefit from proven nutritional ingredients that optimize brain function. 

A recent study published in the Journal of Nutrition found increased levels of DHA improved nonverbal reasoning, mental flexibility, working memory and vocabulary in people between age 35 and 54. Kids also benefit from omega-3. Studies show children who had increased amounts of omega-3 fatty acids performed better in school, including reading and in spelling, and had fewer behavioral problems. Babies with higher DHA levels have better mental and visual function. In addition, children who were breastfed tend to have higher IQ scores and better academic performance than those who were formula-fed; this is believed to be partly related to the high DHA content of breast milk.

Our brains are need omega-3 for memory, performance and behavioral function. Omega-3 oils improve brain function, decrease inflammation, reduce the incidence of fatal heart attacks and ischemic strokes, improve the outcome of autoimmune diseases, and improve vision.

Eico-sapentaenoic acid (EPA) and docosahexaeonic acid (DHA). These two components make up the bulk of the omega-3 oils. The ratio of EPA and DHA can vary considerably in commercial products, however, most of which have much higher concentrations of EPA. Yet, studies have shown that most of the neurological benefits of omega-3 oils are derived from the DHA component rather than the EPA component.

The average DHA and EPA intake combined in the USA is about 100-200 mg/day, far below the 650 mg of DHA plus EPA that experts recommend for healthy individuals.

NowforKids

24K

GlucAffect

RCN# 173198904
Reliv.com

Dr. Alfredo Galvez

Renowned research scientist at the Center of Excellence in Nutritional Genomics at UC Davis and lead scientific advisor at SL Technologies, a Reliv subsidiary. Dr. Galvez first discovered lunasin in 1996 during research at UC Berkley to improve the nutritional profile of soy protein. Dr. Galvez serendipitously discovered the anti-cancer properties of the lunasin peptide, while working as a postdoctoral researcher on a project to increase the methionine content of soy protein at UC Berkeley in the late 1990's.

Lunasin was first investigated as a factor that might prevent cancer cells from dividing and multiplying. Dr. Galvez made his initial discoveries as part of Professor De Lumen's team at UC Berkeley. He discovered that the soy protein "lunacin" could prevent normal cells from becoming cancerous. He says "I immediately knew it would have some practical effect for the health benefit of man-kind." In addition, unlike other cancer preventive agents, while killing off potentially cancerous cells, the peptide poses no detriment to neighboring healthy cells. It even significantly reduces the risk of those cells becoming cancerous as well. Their team called it Lunasin, after the Filipino word “lunas” which means “cure.” 

More than 40 peer-reviewed and published studies have affirmed the health benefits of Lunasin ever since its discovery (“Lunasin Research,” 2011). This discovery has contributed greatly in the search for more natural and accessible cancer prevention methods and has definitely brought pride to the Filipino people. The mechanism of action for Lunasin and cancer prevention was included in prestigious journals, such as Nature Biotechnology and the Journal of Cancer Research. As Dr. Galvez continued to study Lunasin, it became evident that the soy peptide had another powerful mechanism of action– lowering cholesterol. 

While soy has long been linked to heart health, recent studies indicate that protection of the lunasin peptide component so that sufficient amounts are bioavailable once inside the body is the key to its ability to lower LDL (bad) cholesterol.

Dr Galvez says "since it comes form a natural source, it's already considered safe by the FDA. Although Lunasin was first recognized as a key factor for stopping cancer cells from replicating, further studies showed that the soy peptide also had another powerful property—sufficient amounts of lunasin peptide in one’s system can effectively lower LDL (bad) cholesterol.

The FDA had previously approved soy for the prevention of cardiovascular disease.  In 2012 lunasin researcher Alfredo Galvez identified that lunasin was the aspect of soy protein responsible for this medical application. The American Heart Association has endorsed the benefits of lunasin and published Dr Galvez’s research. (sourced from Lunasin.com and Wikipedia.org)

Studies have shown evidence that lunasin has cholesterol-lowering properties. Longer term associations between the eating of soy beans and soy products, and the lowering of cholesterol, have been attributed to lunasin. The process by which lunasin lowers cholesterol, is the inhibition of enzymes present in the liver, by reducing the gene expression for HMG-CoA reductase. Lunasin also has been shown to increase the transcription of LDL receptor mRNA, which allows better passage of plasma LDL cholesterol.

The lower incidence of breast cancer among Asian women compared with Western countries has been partly attributed to soy in the Asian diet, leading to efforts to identify the bioactive components that are responsible. Soy Bowman Birk Inhibitor Concentrate (BBIC) is a known cancer preventive agent now in human clinical trials. Methodology/Principal Findings: The objectives of this work are to establish the presence and delineate the in vitro activity of lunasin.